Drug Discovery AIbriefings.

A luminous DNA strand splits into two diverging paths of blue and amber light across a dark laboratory floor.

Pharma's AI Pipeline Is Running on Two Regulatory Clocks

Drug discovery AI is accelerating faster than either the EU AI Act or FDA's generative AI framework can stabilize, forcing pharma to classify now or re-litigate later.